Opus Genetics (IRD) insider trading in the last 6 months

5 insiders sold $10.6M. No buys.

Quality Score-1Poor

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 12 tradesSee it live, free until tomorrow morning. No account. No card. Then keep going with a free account.

Form 4 filings, newest first

SellGeorge Magrath$110KChief Executive Officerat $3.90 on Nov 3, filed Nov 5

SellGeorge MagrathChief Executive Officer$110Kat $3.90 on Nov 3, filed Nov 5

SellBenjamin R. Yerxa$90KPresidentat $3.53 on Oct 23, filed Oct 27

SellBenjamin R. YerxaPresident$90Kat $3.53 on Oct 23, filed Oct 27

SellGeorge Magrath$34KChief Executive Officerat $3.59 on Oct 23, filed Oct 27

SellGeorge MagrathChief Executive Officer$34Kat $3.59 on Oct 23, filed Oct 27

From SEC Form 4s, the newest filed Nov 5, 2026 · Insiders have 2 business days to file a trade

9 more filings on IRD in the last 6 months, for Pro members. See them free →

Pro members see every filing on IRD with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at Opus Genetics

Insider trades by person

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Questions about IRD's insider trades

As of Nov 9, 2026: Opus Genetics (IRD) has 12 insider filings on record in the last 6 months, the newest filed Nov 5, 2026. Its Quality Score is -1 (Poor). Scores as of 8:42 AM ET, 15 minutes behind.

Are IRD insiders buying or selling?

5 insiders sold $10.6M across 12 filings in the last 6 months. No open-⁠market buys on record. The newest filing: George Magrath, Chief Executive Officer, sold $110K on Nov 3, 2026.

Who are IRD's biggest insider sellers?

By the dollars of their sales in the last 6 months: Foundation Fighting Blindness Retinal Degeneration Fund (Director), 2 sales; George Magrath (Chief Executive Officer), 3 sales; Robert E. Gagnon (Chief Financial Officer), 2 sales. 5 insiders sold in all.

When did an IRD insider last buy?

No IRD insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by George Magrath on Nov 3, 2026.

Opus Genetics's page has its Quality Score, its chart, and its earnings. More in Healthcare and Pharma.

Opus Genetics (IRD) insider trading in the last 6 months

Form 4 filings, newest first

Who files at Opus Genetics

Questions about IRD's insider trades

Every insider trade, with its stock's score.